Brief: Vamorolone Demonstrates On-Target Glucocorticoid Activity Without The Immunosuppression Characteristic Of Traditional Corticosteroids At Clinical Doses
30/06/2026 13:42
BRIEF-Vamorolone Demonstrates On-Target Glucocorticoid Activity Without The Immunosuppression Characteristic Of Traditional Corticosteroids At Clinical Doses June 30 (Reuters) - Catalyst Pharmaceuticals Inc CPRX.O:
VAMOROLONE DEMONSTRATES ON-TARGET GLUCOCORTICOID ACTIVITY WITHOUT THE IMMUNOSUPPRESSION CHARACTERISTIC OF TRADITIONAL CORTICOSTEROIDS AT CLINICAL DOSES
CATALYST PHARMACEUTICALS - VAMOROLONE SHOWS NO SIGNIFICANT IMMUNOSUPPRESSION AT CLINICAL DOSES IN PHASE 1 STUDY
Source text: ID:nGNX9n30HW
Further company coverage: CPRX.O
((Reuters.Briefs@thomsonreuters.com;))